Mitchell Clark

8PUBLICATIONS

57CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsInnate immunityPredictive and prognostic markersFoetal development and medicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 14, 2026

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Apr 16, 2024

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.

Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle

|Apr 09, 2024

Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

|Sep 07, 2023

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.

Levent Mutlu, Diego D Manavella, Stefania Bellone

|Aug 28, 2023

Delayed presentation of placenta accreta following a first-trimester medical abortion.

Jenna Maurer, Sangeeta Ramani, Bo Xu

|Nov 17, 2021

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin.

Mitchell Clark, Alexandra Kollara, Theodore J Brown

Pageof 2

Frequent Collaborators

Alessandro D Santin

Vaagn Andikyan

Peter E Schwartz

Gloria S Huang

Natalia Buza

Eric Siegel

Elena S Ratner

Blair McNamara

Stefania Bellone

Gary Altwerger

Frequent Collaborators

Alessandro D Santin

Vaagn Andikyan

Peter E Schwartz

Gloria S Huang